Professor Alex Richter

📣Professor @AlexRichter3 presenting "Testing times: developing diagnostics to meet contemporary healthcare challenges" @bsicongress @ImmunologyUoB @BSI_Midlands @unibirmingham @BSI_CIPN

👇STRAVINSKY is the largest most comprehensive study of immunity across 20 clinically vulnerable groups. Thank you to all our participants and looking forward to sharing our results in the autumn in our public webinar 🙏 @ResearchFIRSTB

Great to be able to contribute to this publication. How do we rethink diagnostics to reduce cost and increase access 🧐👇

🩸 Researchers from @CISUoB – a PHTA anchor resident – have received £230k of translational funding from @CR_Horizons to develop a prototype for a new test to monitor people at risk of developing the blood cancer multiple myeloma 👇 phta.co.uk/new-test-to-mo… @AlexRichter3

Excited to share our work on Pregnancy Loss at the 3rd Birmingham Translational Research Symposium! @unibirm_TRT #UoB_TRS2025

🚨 Registration is now open for the BSI-CIPN Conference 2025! Join clinical immunology professionals in Liverpool this December for cutting-edge science, practical insights & expert-led discussions #BSICIPN25 🔗 Save with early bird & member discounts! bit.ly/4lvXDC4

So excited to have been shortlisted for this 👇Thank you to whoever nominated me :) It’s a public vote so grateful to all those who vote!

Great to see this study published. The dried blood spot experience must have opened up valuable lessons for how we approach testing under pressure really insightful

Excited to be in Sheffield today highlighting dilemmas for immune vulnerable when it comes to measles and MMR live vaccine #UKCVN2025

Multi disciplinary discussion on early stage T1D - so much still to work out and learn with immunotherapy hopefully coming soon to modulate diabetes progression

Great to finally get this paper out! The DBS assay has been the bedrock of the ELSA screening program and this paper demonstrates user acceptability and lab accuracy. @DUK_research @BT1DUK @elsadiabetes

Delighted to publish our validation of T1D antibodies using dried blood spot sampling🩸 onlinelibrary.wiley.com/doi/10.1111/dm…

Just getting ready for our spring webinar this evening. ✔️ Update on @STRAVINSKYstudy ✔️Beyond Covid - other infection risks ✔️From research to impact

Representing @BSI_CIPN for a #WorldImmunisationWeek parliamentary event to highlight the importance of including immune-vulnerable groups in #vaccine clinical trials. Showed data from @STRAVINSKYstudy reporting later this year on value of biomarkers as a risk of severe infection

I had wonderful opportunity to highlight the importance of vaccination for the immune vulnerable and the need for global access at an affordable price for the vaccine and its delivery #worldimmunisationweek @BactiVac @UoBinfectionsch @CISUoB

Excited to be preparing for our next public webinar with updates on @STRAVINSKYstudy and an update on wider infection risk in clinically vulnerable patients 👇 Let me know if any burning qs

Our new lab home is nearly ready! @CISUoB @UoBinfectionsch @PHTA_Ltd

Are you aged 18–25, from a minority ethnic background, and living with type 1 diabetes? Your lived experience can help make diabetes tech more inclusive. Join a 2-hour online session to share how research findings should be shared — and get £50 for your time. 💬 🔗 Fill out the…

👇@DocSteveTaylor recruiting women for a #HIV prevention study. He led amazing work to expand viral testing in a&e with universal testing unless opt out 🙌 Prevention and early detection ✔️

👇Amazing opportunity birmingham.ac.uk/Documents/the-…